Overview and Scope
High-throughput screening (HTS) is a technique employed in drug discovery and various scientific domains to rapidly assess a large number of samples for biological activity. Its purpose is to identify active compounds, antibodies, or genes that modulate specific biological pathways, thereby expediting the drug discovery process.
Sizing and Forecast
The high throughput screening market size has grown rapidly in recent years. It will grow from $20.66 billion in 2023 to $22.98 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing adoption of high-throughput screening, rising r&d spending, growing availability of funds for research, increasing healthcare spending, competitive market landscape.
The high throughput screening market size is expected to see strong growth in the next few years. It will grow to $33.1 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing market size and growth rate, strategic developments by key players, rising demand for disease monitoring and drug discovery, rising prevalence of chronic diseases, growing focus towards implementation of ultra high throughput screening (UHTS) techniques. Major trends in the forecast period include technological advancements in high-throughput screening, growing focus towards implementation of ultra high throughput screening (UHTS) techniques.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
Segmentation & Regional Insights
The high throughput screening (HTS) market covered in this report is segmented –
1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-on-a-chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users
North America was the largest region in the high throughput screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of chronic diseases is expected to propel the growth of the high-throughput screening (HTS) market going forward. Chronic disease refers to a long-term health condition or disease that persists over an extended period, typically lasting for three months or more. HTS enables rapid screening of numerous chemical compounds to pinpoint potential drug candidates targeting specific pathways or mechanisms implicated in chronic diseases, essential for their effective long-term management For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based medical library run by the federal government, the number of people aged 50 and older with one or more chronic diseases is expected to increase by 99.5%, totaling 142.66 million by 2050, compared to 71.522 million in 2020 in the United States of America. Therefore, the rise in the prevalence of chronic diseases will drive the growth of the high-throughput screening (HTS) market.
Key Industry Players
Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o
The high throughput screening (hts) market report table of contents includes:
1. Executive Summary
2. High Throughput Screening (HTS) Market Characteristics
3. High Throughput Screening (HTS) Market Trends And Strategies
4. High Throughput Screening (HTS) Market – Macro Economic Scenario
5. Global High Throughput Screening (HTS) Market Size and Growth
.
.
.
32. Global High Throughput Screening (HTS) Market Competitive Benchmarking
33. Global High Throughput Screening (HTS) Market Competitive Dashboard
34. Key Mergers And Acquisitions In The High Throughput Screening (HTS) Market
35. High Throughput Screening (HTS) Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
